Two More NovaSeq™ X Plus: CeGaT Expands Sequencing Power
With four NovaSeq™ X Plus systems now in operation, we provide the high-throughput sequencing power required to deliver…
CeGaT GmbH
CeGaT Introduces CancerMRD: Personalized and Non-Invasive Tumor Monitoring
CeGaT GmbH, a global provider of genetic diagnostics and sequencing services, proudly announces the launch of CancerMRD,…
CeGaT Enhances ExomeXtra® for Deeper Genetic Insights
CeGaT, a global provider of genetic diagnostics and sequencing services, announces significant advancements in exome dia…
CeGaT Expands Genetic Testing Services to U.S. and Canada, Partnering with Major Insurers
CeGaT, a global provider of genetic testing and sequencing services, announces the expansion of its world-class genetic…
CeGaT hat mehrfach Grund zu feiern
CeGaT, ein weltweiter Anbieter von genetischer Diagnostik und Sequenzierdienstleistungen mit Sitz in Tübingen, feiert d…
CeGaT Has Multiple Reasons to Celebrate
CeGaT, a global provider of genetic diagnostics and sequencing services based in Tübingen, Germany, is celebrating sever…
CeGaT Revolutionizes Exome Diagnostics with Genome-wide CNV Analysis
CeGaT, a global provider of genetic diagnostics and sequencing services, presents an innovation in exome diagnostics: Wi…
CeGaT Is One of the First Companies Worldwide to Receive the Most Powerful Sequencing Platform NovaSeq™ X Plus
CeGaT, a global provider of sequencing services for research, clinical studies, and human genetic diagnostics, is now us…
CeGaT erhält als eines der ersten Unternehmen weltweit die leistungsstärkste Sequenzierplattform NovaSeq™ X Plus
CeGaT, ein global agierender Anbieter von Sequenzierdienstleistungen für Forschung, klinische Studien und humangenetisc…
First Provider in Germany: CeGaT Offers Sequencing Services Based on PacBio's SMRT Technology
CeGaT, a global provider of sequencing services for research, clinical trials, and human genetic diagnostics, is the fir…
